2nd Annual Orphan Drug Congress 2012
June 7 - 8, 2012
Barcelona, Spain
The Annual Orphan Drug Congress covers topics such as:
- Regulatory challenges surrounding Orphan drug development
- Successful development plan for Orphan Drug
- Commercial aspects of orphan drug development
- Developing patient registries
- Patient perspective
The Annual Orphan Drug Congress brings together:
- CMO, CEO, Corporate Development and CSO from biotechnology companies
- VPs, Presidents, Heads/Managers and Directors of (within sectors – CV, Oncology, AutoImmune and Respiratory): Therapeutic Development, (Orphan) Drug Discovery/Development, Business Unit, Marketing & Medical Affairs, External Affairs, Regulatory Affairs and Market Access From pharmaceutical companies
- Academics, Regulatory Bodies and Research centres
Venue
Not final
Address
Barcelona,
Spain
Spain
Organization
Categories
Important
Please, check the conference website for possible changes, before you make any traveling
arrangements
* Prices are for evaluation only.
Articles/News/Press releases
- Medical conferences—establishing awareness in medical fields
- Technology conferences — a useful tool
- A Study of clinical profile and treatment outcome of DOTS regime in 250 pulmonary and extra pulmonary patients in Hamidia hospital ,Bhopal in the year 2011
- Corneal endothelial recovery in patients undergoing small incision cataract surgery comparison between diabetics and non diabetics.
- Effect of pegylated interferon and ribavirin used for treatment of chronic hepatitis C patients on semen parameters
- Estimation of Serum Leptin Levels in Patients with chronic hepatitis C (CHC)
